Paresthesia-Free Fast-Acting Subperception (FAST) Study
NCT ID: NCT04618471
Last Updated: 2025-12-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
177 participants
INTERVENTIONAL
2021-02-10
2029-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
WaveWriter Settings
Boston Scientific WaveWriter SCS System
WaveWriter SCS Programming
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Boston Scientific WaveWriter SCS System
WaveWriter SCS Programming
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 22 years of age or older when written informed consent is obtained
* Able to independently read and complete all questionnaires and assessments provided in English
* Signed a valid, IRB-approved informed consent form (ICF) provided in English
Exclusion Criteria
* Significant cognitive impairment that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
* Breast-feeding or planning to get pregnant during the course of the study or not using adequate contraception
* Participating, or intends to participate, in another clinical trial that may influence the data that will be collected for this study
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natalie Bloom Lyons
Role: STUDY_DIRECTOR
Boston Scientific Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vitamed Research
Palm Desert, California, United States
Denver Back Pain Specialists
Greenwood Village, Colorado, United States
Orlando Health Neuroscience Institute
Clermont, Florida, United States
The Orthopaedic Institute
Gainesville, Florida, United States
University of Chicago Hospital
Chicago, Illinois, United States
Goodman Campbell Brain and Spine
Carmel, Indiana, United States
Willis-Knighton River Cities Clinical Research Center
Shreveport, Louisiana, United States
Montefiore Medical Center
The Bronx, New York, United States
The Center for Clinical Research
Winston-Salem, North Carolina, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Pacific Sports and Spine, LLC
Eugene, Oregon, United States
PCPMG Clinical Research Unit, LLC
Greenville, South Carolina, United States
Acute and Chronic Pain Therapies
Bellevue, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A4099
Identifier Type: -
Identifier Source: org_study_id